Valeant Offers to Buy Allergan With Pershing’s Support – Bloomberg

Bloomberg
Valeant Pharmaceuticals International Inc. (VRX) offered to buy Allergan Inc. (AGN), maker of the Botox wrinkle treatment, in a cash-and-stock deal valued at $45.7 billion in the latest step of the Canadian company’s plan to become one of the world’s largest …
Allergan says it ‘will carefully review’ Valeant offerLos Angeles Times
Valeant Pharmaceuticals Is a Popular Play Among Hedge FundsWall Street Journal
RLPC-Valeant nets $15.5 bln debt financing for Allergan buyReuters
New York TimesTelegraph.co.ukUSA TODAY
all 527 news articles

…read more

Source: Business News From Google News

Leave a Comment